Oct 19, 2020
Endo to Acquire BioSpecifics to Enhance Profitability of XIAFLEX® and Qwo(TM)
Sep 08, 2020
BioSpecifics to Present at the H.C. Wainwright Virtual Healthcare Conference
Aug 10, 2020
BioSpecifics Reports Second Quarter 2020 Financial and Operating Results
Jul 20, 2020
BioSpecifics Appoints Alex Monteith as Chief Business Officer
May 11, 2020
BioSpecifics Reports First Quarter 2020 Financial and Operating Results
Apr 10, 2020
BioSpecifics Adopts Replacement Stockholder Rights Plan
Apr 09, 2020
BioSpecifics Appoints Mike Sherman and Corey Fishman to Board of Directors
Nov 08, 2019
BioSpecifics Reports Third Quarter 2019 Financial and Operating Results
Oct 10, 2019
BioSpecifics Technologies Corp. Names J. Kevin Buchi as Chief Executive Officer
Aug 09, 2019
BioSpecifics Technologies Corp. Reports Second Quarter 2019 Financial and Operating Results
May 10, 2019
BioSpecifics Technologies Corp. Reports First Quarter 2019 Financial and Operating Results
Apr 02, 2019
BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2018 Financial Results
Mar 18, 2019
BioSpecifics Technologies Corp. Announces Passing of President Thomas L. Wegman
Nov 15, 2018
BioSpecifics Technologies Corp. Appoints Ron Law, Ph.D, J.D., as Senior Vice President of Business Development
Oct 31, 2018
BioSpecifics Technologies Corp. Announces Positive Topline Results from Phase 1 Study of CCH for the Treatment of Uterine Fibroids
Aug 09, 2018
BioSpecifics Technologies Corp. Reports Second Quarter 2018 Financial Results
May 09, 2018
BioSpecifics Technologies Corp. Reports First Quarter 2018 Financial Results
Mar 14, 2018
BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2017 Financial Results
Mar 12, 2018
BioSpecifics Technologies Corp. Announces Presentation of Interim Data from Phase 1 Study of CCH for the Treatment of Uterine Fibroids at 65th Annual Scientific Meeting of the Society for Reproductive Investigation
Jan 22, 2018
BioSpecifics Technologies Corp. to Present at the NobleCon14 Conference